Caleb Rans, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Tue, 05 Mar 2024 14:37:40 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Caleb Rans, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 The Role of Physician-AI Interaction in the Treatment of Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-role-physician-ai-interaction-treatment-risk/ Tue, 05 Mar 2024 14:25:00 +0000 https://www.oncologynurseadvisor.com/?p=117083 Doctor on computer.Researchers sought to determine the potential role for physician-AI interactions in the treatment of patients with multiple myeloma.]]> Rethinking the Development of CAR T-Cell Products for Pediatric Cancer https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/pediatric-cancer-rethinking-cart-cell-products-development-risk/ Wed, 27 Dec 2023 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=115164 pediatric patient hospital bed backA group of experts discussed alternative strategies for the development of CAR T-cell products in the context of pediatric cancer.]]> Dostarlimab Plus Chemo Deemed New Standard Care for Endometrial Cancer https://www.oncologynurseadvisor.com/home/cancer-types/gynecologic-cancer/dostarlimab-chemo-new-standard-care-endometrial-cancer/ Mon, 03 Apr 2023 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=106300 IV infusionAdding dostarlimab to chemotherapy can improve outcomes in patients with primary advanced or recurrent endometrial cancer, a phase 3 trial suggests.]]> nsRPLND Appears Safe, Effective in Low-Volume Metastatic Seminoma https://www.oncologynurseadvisor.com/home/cancer-types/genitourinary-cancer/nsrplnd-appears-low-volume-metastatic-seminoma-safe-effective/ Thu, 23 Feb 2023 15:30:00 +0000 https://www.oncologynurseadvisor.com/?p=105237 SurgeonsNerve-sparing retroperitoneal lymph node dissection appears safe and effective for patients with low-volume metastatic seminoma. ]]> British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia https://www.oncologynurseadvisor.com/home/cancer-types/leukemia/chronic-myeloid-leukemia/british-society-for-haematology-guidelines-for-cml-diagnosis-managements/ Fri, 23 Oct 2020 14:13:41 +0000 https://www.oncologynurseadvisor.com/?p=85953 A doctor sits at his desk, working hard.The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children. ]]> Clonal Hematopoiesis in Hematologic Malignancies, Bone Marrow Failure Syndromes, and Stem Cell Clones https://www.oncologynurseadvisor.com/home/cancer-types/hematologic-cancers/clonal-hematopoiesis-hematologic-malignancies-bone-marrow-failure-syndromes-stem-cell-clones/ Fri, 04 Sep 2020 15:20:43 +0000 https://www.oncologynurseadvisor.com/?p=83781 Bone marrow aspirationRecent studies have better elucidated the link between clonal hematopoiesis and hematologic malignancies. ]]> New ASCO Clinical Guidelines on Management of Cancer Cachexia https://www.oncologynurseadvisor.com/home/hot-topics/side-effect-management/cancer-cachexia-american-society-of-clinical-oncology-guidelines/ Thu, 25 Jun 2020 19:02:11 +0000 https://www.oncologynurseadvisor.com/?p=81404 This fact sheet provides an overview of the updated ESMO clinical practice guideline for hereditary GI cancers.The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.]]> Improving the Clinical Diagnosis and Classification of Gray Zone Lymphomas https://www.oncologynurseadvisor.com/home/cancer-types/lymphoma/gray-zone-lymphoma-clinical-features-and-diagnostic-process/ Thu, 26 Sep 2019 14:00:34 +0000 https://www.oncologynurseadvisor.com/?p=68019 Current treatment strategies for immune thrombocytopenic purpura are centered on immunomodulation and decreasing platelet destructionAlthough gray zone lymphoma has distinct morphologic features, immunophenotyping can make classifying gray zone lymphoma challenging.]]>